RecallRadar

FDA Device recall Z-1099-2017

Accu-Chek Connect Diabetes Management App

On 2017-02-01 the FDA classified a Class II recall of Accu-Chek Connect Diabetes Management App by Roche Diabetes Care, citing iOS and Android: Under certain conditions the affected app versions may disregard historical bolus data potentially leading to an incorrect bolus insulin recommendation being prov….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1099-2017
ClassificationClass II
Statusterminated
Initiated2016-12-20
Published2017-02-01
Last updated2026-09-13 11:54 UTC
CompanyRoche Diabetes Care
DistributionUS

Product

Accu-Chek Connect Diabetes Management App

Reason

iOS and Android: Under certain conditions the affected app versions may disregard historical bolus data potentially leading to an incorrect bolus insulin recommendation being provided to the user. iOS only: Pairing and using multiple meters with the Accu-Chek Connect app can under rare circumstances cause the bolus advisor to fail to offer a correction bolus recommendation within the eligible time window following a blood glucose measurement (10  15 minutes). Depending on the individual metabolic situation potentially incorrect bolus advice could lead to serious health consequences such as hypoglycemia. Both software issues may also cause the amount of active insulin displayed during the bolus calculation process to be incorrect and should not be used to manually calculate a bolus.

Identifiers

code_infoCatalog number 07562462001 / GTIN number 00365702700000 Catalog number 07250452001 / GTIN number 00365702700017

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1099-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.